ULBP2 and neoplasm: miR-34a and miR-34c have been shown to enhance NK-cell killing activity against melanoma cells by targeting the UL16 binding protein 2, while miR-34 mimics led to down-regulation of ULBP2, diminishing tumor cell recognition by NK cells [85].